approval
saveKOSELUGO (SELUMETINIB) — FDA approval
community read0 votes
Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalKOSELUGO (SELUMETINIB SULFATE) — FDA approvalNov 19, 2025 · 319d ago
- approvalKOSELUGO (SELUMETINIB SULFATE) — FDA approvalSep 10, 2025 · 389d ago
- approvalKOSELUGO (SELUMETINIB) — FDA approvalSep 10, 2025 · 389d ago
- approvalKOSELUGO (SELUMETINIB SULFATE) — FDA approvalJan 24, 2024 · 984d ago
- approvalKOSELUGO (SELUMETINIB SULFATE) — FDA approvalDec 22, 2021 · 1747d ago
- approvalKOSELUGO (SELUMETINIB SULFATE) — FDA approvalApr 10, 2020 · 2368d ago
same company · ±60 days · 6
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB SULFATE) — FDA approvalNov 19, 2025
- approvalcapivasertib: TRUQAP (CAPIVASERTIB) — FDA approvalNov 14, 2025
- approvalIMFINZI (DURVALUMAB) — FDA approvalNov 25, 2025
- approvaleplontersen sodium: WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalDec 17, 2025
- recallASTRAZENECA PHARMACEUTICALS recall (Cls II)Oct 22, 2025
- approvalnirsevimab: BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalOct 20, 2025
comments(0)
5-min edit window · permanent after that